Alpidem

This classification denotes a sedative and hypnotic with the molecular formula C21H23Cl2N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I93SC245QZ, chemically known as 6-chloro-2-(p-chlorophenyl)-n,n-dipropylimidazo(1,2-a)pyridine-3-acetamide but generally known as alpidem, which bears US NIH Compound Identifier 54897. European Medicines Agency schedules Alpidem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05367MIG. The term ALPIDEM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). ALPIDEM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alpidem under HS 29339990 and SITC 51577. As of Q4 2014, ALPIDEM remains the US FDA Preferred Term for this commodity. Alpidem bears US NLM identifiers UMLS ID C0051484 and NCI Concept Code C80669. SMILES: CLC1CN2C(CC(=O)N(CCC)CCC)C(NC2CC1)C1CCC(CL)CC1.